INSIGHT - Imlepmentation of Presonalized Medicine in NSCLC: EGFR testing, histopatological an clinical features

• 
• 

Chief Investigator:

Rafał Dziadziuszko, MD, PhD

Sponsor:

Masaryk University

Study Coordinator:

Alicja Maciejewska-Izdebska MSc, CEEOG

Study title:

INSIGHT – Imlepmentation of Presonalized Medicine in NSCLC: EGFR testing, histopatological an clinical features

Start date:

15.05.2012

Study status:

Closed

Background:

Registry is a multinational , multicenter database of adult patients with a non-small cell lung carcinoma with a positive EGFR mutation treated with tyrosine kinase inhibitors. The aim of this project is to document the profile of NSCLC patients undergoing EGFR mutation testing and document the clinical management.

Publications:

Ramlau R, Cufer T, Berzinec P, Dziadziuszko R, Olszewski W, Popper H, Bajcic P, Dusšk L, Zbozinkova Z, Pirker R; INSIGHT study team. Epidermal Growth Factor Receptor Mutation-Positive Non-Small-Cell Lung Cancer in the Real-World Setting in Central Europe: The INSIGHT Study, J Thorac Oncol. 2015 Sep;10(9):1370-1374

 

• < Prev
• Next >